SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ZONAGEN INC (CIK 0000897075) — Jan 24, 2005

ZONAGEN INC (CIK 0000897075)
Date: Jan. 24, 2005 · CIK: 0000897075 · Accession: 0000950129-05-000526

AI Filing Summary & Sentiment

File numbers found in text: 333-119861

Date
January 24, 2005
Author
Not clearly detected
Form
CORRESP
Company
ZONAGEN INC (CIK 0000897075)

Letter

450 5th Street, N.W. Washington, D.C. 20549 Attn: Mr. Jeffrey Riedler:

Re: Registration Statement on Form S-1 under the Securities Act 1933, as amended (Registration No. 333-119861), filed by Zonagen, Inc.

Dear Mr. Riedler:

Zonagen, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that such Registration Statement becomes effective at 4:00 p.m., Washington, D.C. time, on January 26, 2004, or as soon thereafter as is practicable. Please contact Paul Aubert at (281) 681-5934 once the Registration Statement is declared effective.

ZONAGEN, INC.

By: /s/ Louis Ploth, Jr.

Louis Ploth, Jr.

Vice President, Business Development, Chief Financial Officer and Secretary

Show Raw Text
CORRESP
1
filename1.htm

corresp

[ZONAGEN LETTERHEAD]

January 24, 2005

The Securities and Exchange Commission

450 5th Street, N.W.

Washington, D.C. 20549

Attn: Mr. Jeffrey Riedler:

         Re:
    Registration Statement on Form S-1 under the Securities Act 1933, as amended
(Registration No. 333-119861), filed by Zonagen, Inc.

Dear Mr. Riedler:

     Zonagen, Inc. hereby requests that the effectiveness of the above-referenced Registration
Statement be accelerated so that such Registration Statement becomes effective at 4:00 p.m.,
Washington, D.C. time, on January 26, 2004, or as soon thereafter as is practicable. Please
contact Paul Aubert at (281) 681-5934 once the Registration Statement is declared effective.

    ZONAGEN, INC.

    By:
    /s/ Louis Ploth, Jr.

    Louis Ploth, Jr.

    Vice President, Business Development,
Chief Financial Officer and Secretary